Adriá-Cebrián, J.; Guaita-Esteruelas, S.; Lam, E.W.-F.; RodrÃguez-Balada, M.; Capellades, J.; Girona, J.; Jimenez-Santamaria, A.M.; Yanes, O.; Masana, L.; Gumà , J.
MCF-7 Drug Resistant Cell Lines Switch Their Lipid Metabolism to Triple Negative Breast Cancer Signature. Cancers 2021, 13, 5871.
https://doi.org/10.3390/cancers13235871
AMA Style
Adriá-Cebrián J, Guaita-Esteruelas S, Lam EW-F, RodrÃguez-Balada M, Capellades J, Girona J, Jimenez-Santamaria AM, Yanes O, Masana L, Gumà J.
MCF-7 Drug Resistant Cell Lines Switch Their Lipid Metabolism to Triple Negative Breast Cancer Signature. Cancers. 2021; 13(23):5871.
https://doi.org/10.3390/cancers13235871
Chicago/Turabian Style
Adriá-Cebrián, Jose, Sandra Guaita-Esteruelas, Eric W.-F. Lam, Marta RodrÃguez-Balada, Jordi Capellades, Josefa Girona, Ana Maria Jimenez-Santamaria, Oscar Yanes, LuÃs Masana, and Josep Gumà .
2021. "MCF-7 Drug Resistant Cell Lines Switch Their Lipid Metabolism to Triple Negative Breast Cancer Signature" Cancers 13, no. 23: 5871.
https://doi.org/10.3390/cancers13235871
APA Style
Adriá-Cebrián, J., Guaita-Esteruelas, S., Lam, E. W.-F., RodrÃguez-Balada, M., Capellades, J., Girona, J., Jimenez-Santamaria, A. M., Yanes, O., Masana, L., & Gumà , J.
(2021). MCF-7 Drug Resistant Cell Lines Switch Their Lipid Metabolism to Triple Negative Breast Cancer Signature. Cancers, 13(23), 5871.
https://doi.org/10.3390/cancers13235871